ArticleFrontiers in oncology2024

Phase II trial of vaccination with autologous, irradiated melanoma cells engineered by adenoviral mediated gene transfer to secrete granulocyte-macrophage colony stimulating factor in patients with stage III and IV melanoma.

Tamara A Sussman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.